Membrane-bound IL-2- or IL-12-expressing vvDD avoided the severe toxicity associated with systemic exposure while modulating the TME and induced superior antitumor effects, especially in combination with the PD-1 blockade, curing all or most of the mice with a high tumor burden [48]. This evidence concerns the gene IL2 and neoplasm.